Alpha Tau Medical Ltd. DRTS
13.70 USD -0.41 (-2.91%)
At closeNov 11, 2026, 5:20 AM EST
14.06 +0.36 +2.63%
Pre-market · Nov 11, 5:20 AM ET
13.60 Day range 14.17
3.43 52-week range 15.79
- YTD
- +176.77%
- 1 year
- +249.49%
News
benzinga.com Alpha Tau Medical To Join TASE’s TA-90 and TA-125 Indices On November 5, 2026 Funds that track these TASE benchmark indexes are expected to add Alpha Tau shares to their holdingsTA-125 tracks the 125 largest and most prominent companies on the TASEJERUSALEM, Oct. 29, 2026…
benzinga.com Alpha Tau Medical Inks MoU With Samsung Medical Center In Seoul Regarding Potential Clinical Study In Pancreatic Cancer Patients Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced the signing of an MOU in Seoul, South Korea,…
benzinga.com HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $16 Price Target HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $16 price target.
benzinga.com Alpha Tau Medical Receives FDA Approval For Investigational Device Exemption Supplement To Expand Its U.S. REGAIN Study Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that the U.S. Food and Drug Administration…